Загрузка...
Targeting Disease Persistence in Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors (GISTs) represent 20%–40% of human sarcomas. Although approximately half of GISTs are cured by surgery, prognosis of advanced disease used to be poor due to the high resistance of these tumors to conventional chemo- and radiotherapy. The introduction of molecularly ta...
Сохранить в:
| Опубликовано в: : | Stem Cells Transl Med |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AlphaMed Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479627/ https://ncbi.nlm.nih.gov/pubmed/25934947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2014-0298 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|